Skip to content

Hope restored: The critical role that Minimal Residual Disease can play in blood cancer patient care

Read Post
Logo for Adaptive Biotechnologies
  • Investors
  • |
  • Join Our Team

Main Site Navigation

  • Immune Medicine Menu

    About

    • Immune Medicine Platform
    • The Adaptive Immune System
    • TCR Antigen Map
    • Publications

    Pharma Services

    • Immune Receptor Sequencing

    Drug Discovery

    • TCR Therapeutics
    • Antibody Therapeutics
    • Target Discovery
    • Pipeline
  • MRD

    About

    • Clinical Portfolio & Pipeline
    • Publications

    Clinical Diagnostics

    • clonoSEQ
  • News and Events

    Blog

    • Hope restored: The critical role that Minimal Residual Disease can play in blood cancer patient care
    • Among Multiple Myeloma Patients Receiving MRD Testing, Majority Report Meaningful Benefits
    • A Reflection on Blood Cancer Awareness Month: Patient Spotlight
    • See all posts

    Media

    • Press Releases
    • Media Resources

    Events

    • Conferences & Events
  • Our Science

    Publications

    • Research Publications

    Credentials

    • Licenses & Accreditation

    Medical

    • Medical Affairs
    • Medical Information
    • Data & Congresses
  • About Us

    About Us

    • Who We Are
    • Our Story
    • Innovation Timeline
    • Leadership
    • Corporate Social Responsibility

    Careers

    • Discover Your Story
    • Stories of Adaptive
    • Life at Adaptive
    • Belonging
    • Career Listings

    Connect

  • Contact
  • Investors

    • Investor Relations
    • Newsroom

Blog

Read the latest stories from the Adaptive team

Recent Posts

illustration of female scientist at lab bench

Recognizing the accomplishments of women in science: A conversation with Ana Bolivar, 2021 immunoSEQ WISE award winner

March 29, 2022

Recognizing the accomplishments of women in science: A conversation with Ana Bolivar, 2021 immunoSEQ WISE award winner
Adaptive Biotechnologies logo on dark blue background

A Message from Co-Founder and CEO Chad Robins

March 8, 2022

A Message from Co-Founder and CEO Chad Robins
adaptive-technologies

Molecular Laboratory Operations: The Heartbeat of Adaptive

February 28, 2022

Molecular Laboratory Operations: The Heartbeat of Adaptive
Illustration of Doctor meeting with Patient

Whatever Happens, the Patient Has to be at the Center

February 4, 2022

Whatever Happens, the Patient Has to be at the Center
Adaptive Volunteers march in the PRIDE parade under a balloon arch

It’s more than a number: Pride co-leader Shay Miller on the impact of Adaptive’s high marks on the HRC Corporate Equality Index

January 27, 2022

It’s more than a number: Pride co-leader Shay Miller on the impact of Adaptive’s high marks on the HRC Corporate Equality Index
dark-tcell-bg

Adaptive Computational Biologist Rachel Gittelman on her 2021 STAT Wunderkind Induction

January 14, 2022

Adaptive Computational Biologist Rachel Gittelman on her 2021 STAT Wunderkind Induction
featured_clonseq_640

MRD in Action: Q&A with Dr. Luciano Costa on the MASTER Trial at ASH 2021

January 4, 2022

MRD in Action: Q&A with Dr. Luciano Costa on the MASTER Trial at ASH 2021
Rendering of immune system cels

The Other Side of The Story: Vaccines Must Produce Both Antibodies and T cell Immunity

December 14, 2021

The Other Side of The Story: Vaccines Must Produce Both Antibodies and T cell Immunity
Photo of Todd and Diane Kennedy

My Life as a Care Partner: A Perspective by Diane Kennedy

November 3, 2021

My Life as a Care Partner: A Perspective by Diane Kennedy
Illustrated map of the world showing the connections between people

Remaining Vigilant Against COVID-19 and Future Pandemics Means Opening Our Eyes to the T-Cell Immune Response

September 28, 2021

Remaining Vigilant Against COVID-19 and Future Pandemics Means Opening Our Eyes to the T-Cell Immune Response
Previous Next

While the information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information. The information may change without notice and Adaptive Biotechnologies is not in any way liable for the accuracy of any information printed and stored or in any way interpreted and used by a user.

The latest from Adaptive

Press Releases

Immune Medicine

  • Immune Medicine Platform
  • The Adaptive Immune System
  • TCR Antigen Map
  • Publications

Pharma Services

  • Immune Receptor Sequencing

Drug discovery

  • TCR Therapeutics
  • Antibody Therapeutics
  • Target Discovery
  • Pipeline

MRD

  • Clinical Portfolio & Pipeline
  • Publications

Clinical Diagnostics

  • clonoSEQ

News & Events

  • Press Releases
  • Media Resources
  • Blog
  • Conferences & Events

Our Science

Publications

  • Research Publications

Credentials

  • Licenses & Accreditation

Medical

  • Medical Affairs
  • Medical Information
  • Data & Congresses

About Us

  • Who We Are
  • Our Story
  • Innovation Timeline
  • Leadership
  • Investor Relations
  • Newsroom
  • Contact
  • Careers
Logo for Adaptive Biotechnologies

Diagnostics (888) 552-8988 | Corporate (206) 659-0067 | Research (855) 466-8667

CAP Accredited | College of American Pathologists
Sitemap | Privacy Policy | Cookie Policy | Do Not Sell My Info (CA Residents) | Terms of Service | Code of Conduct
Facebook-f Youtube Twitter Instagram Linkedin-in

© Adaptive Biotechnologies. All Rights Reserved.